SCHARN; Dirk
Patent Applications and Registrations
Patent applications and USPTO patent grants for SCHARN; Dirk.The latest application filed is for "substituted 1h-pyrazolo[4,3-c]pyridines and derivatives as egfr inhibitors".
- SCHARN; Dirk - Berlin DE
- Scharn; Dirk - Vienna AT
| Patent | Date |
|---|---|
| Substituted 1h-pyrazolo[4,3-c]pyridines And Derivatives As Egfr Inhibitors App 20220133734 - ENGELHARDT; Harald ; et al. | 2022-05-05 |
| [1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors Grant 11,261,184 - Engelhardt , et al. March 1, 2 | 2022-03-01 |
| Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors Grant 11,213,520 - Engelhardt , et al. January 4, 2 | 2022-01-04 |
| Benzimidazole compounds and derivatives as EGFR inhibitors Grant 11,174,245 - Boese , et al. November 16, 2 | 2021-11-16 |
| [1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS App 20210332054 - WILDING; Birgit ; et al. | 2021-10-28 |
| New Benzimidazole Compounds And Derivatives As Egfr Inhibitors App 20200377476 - BOESE; Dietrich ; et al. | 2020-12-03 |
| New [1,6]naphthyridine Compounds And Derivatives As Cdk8/cdk19 Inhibitors App 20200291020 - ENGELHARDT; Harald ; et al. | 2020-09-17 |
| New Phenylpyrazolylacetamide Compounds And Derivatives As Cdk8/cdk19 Inhibitors App 20190290637 - ENGELHARDT; Harald ; et al. | 2019-09-26 |
| Compounds for the inhibition of integrins and use thereof Grant 8,927,534 - Zischinsky , et al. January 6, 2 | 2015-01-06 |
| 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators Grant 8,410,134 - Gibson , et al. April 2, 2 | 2013-04-02 |
| Heterocyclic compounds for the inhibition of integrins and use thereof Grant 8,309,735 - Zischinsky , et al. November 13, 2 | 2012-11-13 |
| C5a receptor antagonists Grant 8,071,810 - Schnatbaum , et al. December 6, 2 | 2011-12-06 |
| Method for determining the substrate specificity of an enzyme Grant 8,029,979 - Schneider-Mergener , et al. October 4, 2 | 2011-10-04 |
| Compounds For The Inhibition Of Rotamases And Use Thereof App 20110065760 - KNOLLE; Jochen ; et al. | 2011-03-17 |
| C5a Receptor Antagonists App 20110003756 - Hummel; Gerd ; et al. | 2011-01-06 |
| 8-oxy-quinoline Derivatives As Bradykinin B2 Receptor Modulators App 20100234344 - Gibson; Christoph ; et al. | 2010-09-16 |
| C5a receptor antagonists Grant 7,727,960 - Hummel , et al. June 1, 2 | 2010-06-01 |
| Heterocyclic Compounds For The Inhibition Of Integrins And Use Thereof App 20090203745 - Zischinsky; Gunther ; et al. | 2009-08-13 |
| Compounds For The Inhibition Of Integrins And Use Thereof App 20090104116 - Zischinsky; Gunter ; et al. | 2009-04-23 |
| C5a Receptor Antagonists App 20080220003 - Schnatbaum; Karsten ; et al. | 2008-09-11 |
| C5a Receptor Antagonist App 20080161232 - Hummel; Gerd ; et al. | 2008-07-03 |
| Phenol derivatives and their use as rotamase inhibitors App 20070054904 - Knolle; Jochen ; et al. | 2007-03-08 |
| Method for determining the substrate specificity of an enzymatic activity and a device therefor App 20060234308 - Schneider-Mergener; Jens ; et al. | 2006-10-19 |
| C5a Receptor antagonists App 20060183883 - Hummel; Gerd ; et al. | 2006-08-17 |
| Method for determining the substrate specificity of an enzymatic activity and a device therefor App 20040171097 - Schneider-Mergener, Jens ; et al. | 2004-09-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 